Market Research Logo

Almac Diagnostics Ltd - Product Pipeline Analysis, 2017 Update

Summary

Almac Diagnostics Ltd (Almac Diagnostics), formerly ArraDx Ltd, a subsidiary of Almac Group Ltd, medical diagnostic company that discovers, develops and commercializes diagnostic tests including companion diagnostics. The company’s products pipeline includes ColDx, DDRD, AADx, prostate Dx, and MEK Dx. It offers ColDx, a prognostic assay for stage II/III colon cancer, and DDRD, is a predictive assay for immune-oncology and DNA damaging agent. Almac Diagnostics offers pre-clinical biomarker discovery to companion diagnostic development including regulatory submissions and commercialization. The company’s applications include patient selection, and are utilised in phase I to phase III registrational clinical trials. It operates laboratories in the US and the UK. Almac Diagnostics is headquartered in Craigavon, the UK.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Almac Diagnostics Ltd
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Almac Diagnostics Ltd Company Overview
Almac Diagnostics Ltd Company Snapshot
Almac Diagnostics Ltd Pipeline Products and Ongoing Clinical Trials Overview
Almac Diagnostics Ltd – Pipeline Analysis Overview
Almac Diagnostics Ltd - Key Facts
Almac Diagnostics Ltd - Major Products and Services
Almac Diagnostics Ltd Pipeline Products by Development Stage
Almac Diagnostics Ltd Pipeline Products Overview
2-Gene qPCR LDT
2-Gene qPCR LDT Product Overview
ALM AADx Assay
ALM AADx Assay Product Overview
Angiogenesis Subtype Diagnostic Assay
Angiogenesis Subtype Diagnostic Assay Product Overview
Diagnostic Test - Ovarian Cancer
Diagnostic Test - Ovarian Cancer Product Overview
DNA Damage Response Deficiency Assay - Breast Cancer
DNA Damage Response Deficiency Assay - Breast Cancer Product Overview
DNA Damage Response Deficiency Assay - Colorectal Cancer
DNA Damage Response Deficiency Assay - Colorectal Cancer Product Overview
DNA Damage Response Deficiency Assay - Esophageal Cancer
DNA Damage Response Deficiency Assay - Esophageal Cancer Product Overview
DNA Damage Response Deficiency Assay - Ovarian Cancer
DNA Damage Response Deficiency Assay - Ovarian Cancer Product Overview
NanoStrings’s nCounter Dx Analysis System with FLEX - Companion Diagnostic Assay
NanoStrings’s nCounter Dx Analysis System with FLEX - Companion Diagnostic Assay Product Overview
Next-Generation Sequencing Based Companion Diagnostic Assay
Next-Generation Sequencing Based Companion Diagnostic Assay Product Overview
Prognostic Test - Early Stage Lung Cancer
Prognostic Test - Early Stage Lung Cancer Product Overview
Prognostic Test - NSCLC
Prognostic Test - NSCLC Product Overview
Prostate Cancer Metastatic Assay
Prostate Cancer Metastatic Assay Product Overview
RSPO3 CLIA Assay
RSPO3 CLIA Assay Product Overview
Almac Diagnostics Ltd - Key Competitors
Almac Diagnostics Ltd - Key Employees
Almac Diagnostics Ltd - Locations And Subsidiaries
Head Office
Recent Developments
Almac Diagnostics Ltd, Recent Developments
Oct 23, 2017: Queens University Belfast Leads Largest Study of its Kind to Transform Prostate Cancer Treatment
Jun 13, 2017: Almac Group Awarded U.S. Patents for Ground-breaking “DDRD” Assay
Apr 20, 2017: Almac Group Announces Publication of Prostate Cancer Metastatic Assay Validation
Feb 16, 2017: Almac Diagnostics Appoints Dr Leeona Galligan as Vice President UK Operations
Jul 07, 2015: Almac Group Appoints Dr. John Robson as VP Quality Operations
Aug 14, 2014: Almac Group Announces 348 New Jobs in £54m Investment
Nov 30, 2011: Almac’s Diagnostic Laboratory Receives Accreditation From College Of American Pathologists
Mar 30, 2011: Almac Open CLIA Lab For Biomarker Clinical Trials
Jul 31, 2008: Almac To Develop Prognostic Test For Early Non Small Cell Lung Cancer Announce World's Largest Gene Expression Study
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Almac Diagnostics Ltd Pipeline Products and Ongoing Clinical Trials Overview
Almac Diagnostics Ltd Pipeline Products by Equipment Type
Almac Diagnostics Ltd Pipeline Products by Indication
Almac Diagnostics Ltd, Key Facts
Almac Diagnostics Ltd, Major Products and Services
Almac Diagnostics Ltd Number of Pipeline Products by Development Stage
Almac Diagnostics Ltd Pipeline Products Summary by Development Stage
2-Gene qPCR LDT - Product Status
2-Gene qPCR LDT - Product Description
ALM AADx Assay - Product Status
ALM AADx Assay - Product Description
Angiogenesis Subtype Diagnostic Assay - Product Status
Angiogenesis Subtype Diagnostic Assay - Product Description
Diagnostic Test - Ovarian Cancer - Product Status
Diagnostic Test - Ovarian Cancer - Product Description
DNA Damage Response Deficiency Assay - Breast Cancer - Product Status
DNA Damage Response Deficiency Assay - Breast Cancer - Product Description
DNA Damage Response Deficiency Assay - Colorectal Cancer - Product Status
DNA Damage Response Deficiency Assay - Colorectal Cancer - Product Description
DNA Damage Response Deficiency Assay - Esophageal Cancer - Product Status
DNA Damage Response Deficiency Assay - Esophageal Cancer - Product Description
DNA Damage Response Deficiency Assay - Ovarian Cancer - Product Status
DNA Damage Response Deficiency Assay - Ovarian Cancer - Product Description
NanoStrings’s nCounter Dx Analysis System with FLEX - Companion Diagnostic Assay - Product Status
NanoStrings’s nCounter Dx Analysis System with FLEX - Companion Diagnostic Assay - Product Description
Next-Generation Sequencing Based Companion Diagnostic Assay - Product Status
Next-Generation Sequencing Based Companion Diagnostic Assay - Product Description
Prognostic Test - Early Stage Lung Cancer - Product Status
Prognostic Test - Early Stage Lung Cancer - Product Description
Prognostic Test - NSCLC - Product Status
Prognostic Test - NSCLC - Product Description
Prostate Cancer Metastatic Assay - Product Status
Prostate Cancer Metastatic Assay - Product Description
RSPO3 CLIA Assay - Product Status
RSPO3 CLIA Assay - Product Description
Almac Diagnostics Ltd, Key Employees
Glossary
List of Figures
Almac Diagnostics Ltd Pipeline Products by Equipment Type
Almac Diagnostics Ltd Pipeline Products by Development Stage

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report